Dopamine D1-like and Angiotensin II Type 1 Receptors Counter-Regulate Autophagy and Cell Proliferation in Rat Embryonic Thoracic Vascular Smooth Muscle Cells
International Journal of Molecular Sciences · 29.07.2026 · 27 (15) · 6784
DOI: 10.3390/ijms27156784 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.07.2026. Verfasst von Hewang Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Kidney Disease & Hypertension, The George Washington University School of Medicine & Health Sciences, Washington,…. Hauptthemen laut MEDLINE: Autophagy, Receptor, Angiotensin, Type 1, Cell Proliferation, Muscle, Smooth, Vascular. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
Vascular smooth muscle cells (VSMCs), the contractile cells in the tunica media of blood vessels, maintain vascular tone. The proliferation of VSMCs is an important feature of vascular remodeling that contributes to the regulation of blood pressure. Autophagy, an intracellular self-degrading process that delivers cytoplasmic constituents to lysosomes, plays a vital role in VSMC proliferation. This is regulated by the dopaminergic and renin–angiotensin systems but their interplay in their regulation of autophagy in VSMCs is not well-understood. In rat VSMCs, fenoldopam (Fen), a dopamine D1-like receptor agonist, increased autophagy, as determined by the increase in the protein expressions of microtubule-associated protein 1 light chain (LC)3-II and beclin-1 (BECN1), in a time- and concentration-dependent manner. Conversely, angiotensin II (Ang II), the endogenous Ang II type 1 receptor (AT1R) agonist, decreased the protein expression of LC3-II and BECN1, also in a time- and concentration-dependent manner. The production of cyclic adenosine monophosphate (cAMP) and autophagic LC3-II puncta in VSMCs were increased by Fen and decreased by Ang II. Pre-treatment of VSMCs with Rp-cAMPS, a protein kinase A inhibitor, prevented the Fen-mediated increase and the Ang II-mediated decrease in LC3-II protein expression. Fen decreased, whereas Ang II increased the phosphorylation of P70S6K, a direct downstream mammalian target of rapamycin (mTOR). The inhibitory effect of Fen and stimulatory effect of Ang II on P70S6K phosphorylation were prevented by Rp-cAMPS. Ang II also decreased the Fen-mediated increase in cAMP production, while Fen attenuated the Ang II-mediated increase in cell proliferation, a response that occurs downstream of autophagy. Moreover, Ang II prevented the Fen-mediated inhibition of cell proliferation, an effect that was blocked by losartan, an AT1R antagonist. These results demonstrate that Fen and Ang II counter-regulate autophagy and proliferation of VSMCs via the mTOR pathway, which is cAMP-dependent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Kidney Disease & Hypertension, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
- Department of Pharmacology and Physiology, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
- Department of Pathology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.
- Department of Pediatrics, Georgetown University Medical Center, Washington, DC 20007, USA.
- Center for Molecular Physiology Research, Children's National Research Institute, Washington, DC 20010, USA.
- Independent Researcher, 2324 North Apple Lane, Pocatello, ID 83204, USA.
ORCID-Profile: Hewang Lee, Waleed N Qaddumi, Jacob Polzin, Robin A Felder, Jeffrey B Kopp
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Natural Science Foundation of China
- NHLBI NIH HHS
- US National Institutes of Health
- Second Affiliated Hospital of Dalian Medical University Start-up Funds
Zitieren
APA
Lee, H., Lu, A., Qaddumi, W. N., Amatya, B., Polzin, J., Verma, M., Cadme, R. C., Felder, R. A., Armando, I., Kopp, J. B., & Jose, P. A. (2026). Dopamine D1-like and Angiotensin II Type 1 Receptors Counter-Regulate Autophagy and Cell Proliferation in Rat Embryonic Thoracic Vascular Smooth Muscle Cells. International Journal of Molecular Sciences, 27(15), 6784. https://doi.org/10.3390/ijms27156784
Vancouver
Lee H, Lu A, Qaddumi WN, Amatya B, Polzin J, Verma M, et al. Dopamine D1-like and Angiotensin II Type 1 Receptors Counter-Regulate Autophagy and Cell Proliferation in Rat Embryonic Thoracic Vascular Smooth Muscle Cells. International Journal of Molecular Sciences. 2026;27(15):6784. doi:10.3390/ijms27156784
BibTeX
@article{Lee2026,
author = {Lee, Hewang and Lu, Amy and Qaddumi, Waleed N and Amatya, Bibhas and Polzin, Jacob and Verma, Maithri and Cadme, Raisha C and Felder, Robin A and Armando, Ines and Kopp, Jeffrey B and Jose, Pedro A},
title = {Dopamine D1-like and Angiotensin II Type 1 Receptors Counter-Regulate Autophagy and Cell Proliferation in Rat Embryonic Thoracic Vascular Smooth Muscle Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6784},
doi = {10.3390/ijms27156784}
}
EUVIMED